CCM

Catalio Capital Management Portfolio holdings

AUM $566M
1-Year Est. Return 106.72%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+106.72%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$541M
AUM Growth
+$64M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
50
New
Increased
Reduced
Closed

Top Buys

1
+$31.5M
2
+$20M
3
+$12.4M
4
SUPN icon
Supernus Pharmaceuticals
SUPN
+$11.6M
5
IRON icon
Disc Medicine
IRON
+$11.1M

Top Sells

1
+$30.6M
2
+$25.2M
3
+$19.6M
4
CORT icon
Corcept Therapeutics
CORT
+$17.6M
5
BBIO icon
BridgeBio Pharma
BBIO
+$14.9M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TARA icon
26
Protara Therapeutics
TARA
$284M
$6.53M 1.21%
1,500,793
-125,577
SEPN
27
Septerna Inc
SEPN
$1.12B
$5.54M 1.02%
294,360
CDTX
28
DELISTED
Cidara Therapeutics
CDTX
$5.11M 0.94%
+53,333
KYTX icon
29
Kyverna Therapeutics
KYTX
$542M
$3.52M 0.65%
586,909
ELDN icon
30
Eledon Pharmaceuticals
ELDN
$272M
$2.75M 0.51%
+1,061,132
OM icon
31
Outset Medical
OM
$83.7M
$1.67M 0.31%
118,279
-48,387
MGX icon
32
Metagenomi Therapeutics
MGX
$53.8M
$1.25M 0.23%
528,993
ATAI icon
33
AtaiBeckley Inc
ATAI
$1.74B
$1.04M 0.19%
196,858
HYPR icon
34
Hyperfine
HYPR
$126M
$993K 0.18%
684,541
-75,494
MLTX icon
35
MoonLake Immunotherapeutics
MLTX
$1.21B
$955K 0.18%
133,131
-29,465
KPTI icon
36
Karyopharm Therapeutics
KPTI
$197M
$935K 0.17%
142,984
-3,029
PVLA
37
Palvella Therapeutics
PVLA
$1.82B
$753K 0.14%
+12,010
SNSE icon
38
Sensei Biotherapeutics
SNSE
$43.7M
$139K 0.03%
14,718
CORT icon
39
Corcept Therapeutics
CORT
$4.84B
– –
-239,125
EW icon
40
Edwards Lifesciences
EW
$46B
– –
-390,932
FULC icon
41
Fulcrum Therapeutics
FULC
$538M
– –
-188,304
GILD icon
42
Gilead Sciences
GILD
$166B
– –
-226,875
HALO icon
43
Halozyme
HALO
$7.89B
– –
-191,529
MRSN
44
DELISTED
Mersana Therapeutics
MRSN
– –
-62,697
REPL icon
45
Replimune Group
REPL
$235M
– –
-330,337
TEVA icon
46
Teva Pharmaceuticals
TEVA
$36.3B
– –
-1,170,372
VIR icon
47
Vir Biotechnology
VIR
$1.67B
– –
-388,303
WGS icon
48
GeneDx Holdings
WGS
$1.94B
– –
-61,507
BCAX
49
Bicara Therapeutics
BCAX
$1.5B
– –
-97,800
ZBIO
50
Zenas BioPharma
ZBIO
$1.15B
– –
-215,314
1
2